鼠李糖乳酪杆菌HN001

科学研究

鼠李糖乳酪杆菌HN001在食品和补充剂中使用已有20多年历史，并且已经在100多篇科学出版物中得到验证。该菌株最初是因为高耐酸性而被选为候选益生菌，随后被证明能够在通过人体肠道后仍然存活。^1-3 鼠李糖乳酪杆菌HN001已经在所有生命阶段进行了广泛研究，从初生婴儿到老年人，从孕期到哺乳期女性。最值得注意的是该菌株能够影响免疫系统，对婴幼儿具有长期安全性，能够支持幼年免疫稳态。^3-6此外，鼠李糖乳酪杆菌HN001与La-14联合使用，能够支持健康细菌定殖，促进女性健康。⁷

参考文献:
1. Prasad J, Gill H, Smart J, Gopal PK. Selection and characterisation of Lacticaseibacillus and Bifidobacterium strains for use as probiotics. Int Dairy J. 1998;8:993-1002. 2. Tannock GW, Munro K, Harmsen HJM, Welling GW, Smart J, Gopal PK. Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lacticaseibacillus rhamnosus DR20. Appl Environ Microbiol. 2000;66:2578-2588. 3. Wickens K, Black PN, Stanley TV, et al. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo- controlled trial. J Allergy Clin Immunol. 2008;122(4):788-794. 4. Wickens K, Black PN, Stanley TV, et al. A protective effect of Lacticaseibacillus rhamnosus HN001™ against eczema in the first 2 years of life persists to age 4 years. Clin Exp Allergy. 2012;42(7):1071-1079. 5. Wickens K, Stanley TV, Mitchell EA, et al. Early supplementation with Lacticaseibacillus rhamnosus HN001™ reduces eczema prevalence to 6 years: does it also reduce atopic sensitization? Clin Exp Allergy. 2013;43(9):1048-1057. 6. Wickens K, Barthow C, Mitchell EA, et al. Effects of Lacticaseibacillus rhamnosus HN001™ in early life on the cumulative prevalence of allergic disease to 11 years. Pediatr Allergy Immunol. 2018;29(8):808-814. 7. De Alberti D, Russo R, Terruzzi F, Nobile V, Ouwehand AC. Lactobacilli vaginal colonisation after oral consumption of Respecta® complex: a randomised controlled pilot study. Arch Gynecol Obstet. 2015;292(4):861-867.